Desktop Health, a recently launched developer of 3D printing and biofabrication solutions for personalized medicine by Desktop Metal, Inc., announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of Flexcera Base, a proprietary resin for use in 3D fabrication of high-quality dental prosthetics. Flexcera Base along with the new Flexcera Smile are Desktop Health’s first formulated and optimized digital dental solutions.
“Three years ago, we set out to create a product that addressed the limitations of current 3D printed dental prosthetics – brittleness and poor aesthetics,” said Michael Jafar, President & CEO of Desktop Health.
The need for dental prosthetics is on the rise, with the global dentures market estimated to reach $3.8 billion USD by 20271. In the U.S. alone, more than 36 million are edentulous, meaning they have no natural teeth, with 90% of those wearing dentures2. According to the American Association of Oral and Maxillofacial Surgeons, 69% of adults ages 35 to 44 have lost at least one permanent tooth to an accident, gum disease, a failed root canal or tooth decay3.
The science of printing teeth
Flexcera was developed with the strength of ceramic coupled with long chain chemistry to ensure optimal denture properties. When used exclusively with EnvisionTEC 3D printers, dental providers can print up to eight custom Flexcera dentures in less than two hours.
- High fracture resistance, three times more resistant to fracture than select competitive resins;
- Moisture resistance to prevent staining or discoloration, two times more resistant than a leading competitive formulation; and
- An overall natural aesthetic that offers lifelike tooth translucency and a natural-looking smile.
Flexcera is expected to launch commercially in the U.S. and Canada by the end of June.